Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats

International Journal of Food Microbiology

Volumn 114, Issue 3, 2007, Pages 267-274

  Geier, Mark S ^a,b   Butler, Ross N ^a,b   Giffard, Philip M ^c   Howarth, Gordon S ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Colon; Dextran sulfate sodium; IBD; Probiotics; Rat model

Indexed keywords

DEXTRAN SULFATE; PROBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIFIDOBACTERIUM ANIMALIS; COLITIS; CONTROLLED STUDY; ENTERITIS; GASTROINTESTINAL DISEASE; LACTOBACILLUS FERMENTUM; LACTOBACILLUS RHAMNOSUS; MALE; NONHUMAN; RAT; SPRAGUE DAWLEY RAT; STREPTOCOCCUS THERMOPHILUS;

ANIMALS; BACTERIAL PHYSIOLOGY; COLITIS; COLONY COUNT, MICROBIAL; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; LACTOBACILLUS FERMENTUM; LACTOBACILLUS RHAMNOSUS; MALE; PROBIOTICS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; STREPTOCOCCUS; TREATMENT OUTCOME;

BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS; LACTOBACILLUS FERMENTUM; LACTOBACILLUS RHAMNOSUS; RATTUS; STREPTOCOCCUS THERMOPHILUS;

EID: 33847138191     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2006.09.018     Document Type: Article

References (48)

1. Baharav E., Mor F., Halpern M., and Weinberger A. Lactobacillus GG bacteria ameliorate arthritis in Lewis rats. The Journal of Nutrition 134 (2004) 1964-1969
2. Bibiloni R., Fedorak R.N., Tannock G.W., Madsen K.L., Gionchetti P., Campieri M., De Simone C., and Sartor R.B. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. The American Journal of Gastroenterology 100 (2005) 1539-1546
3. Bruzzese E., Raia V., Gaudiello G., Polito G., Buccigrossi V., Formicola V., and Guarino A. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Alimentary Pharmacology and Therapeutics 20 (2004) 813-819
4. Bulger E.M., and Helton W.S. Nutrient antioxidants in gastrointestinal diseases. Gastroenterology Clinics of North America 27 (1998) 403-419
5. del Campo R., Bravo D., Canton R., Ruiz-Garbajosa P., Garcia-Albiach R., Montesi-Libois A., Yuste F.J., Abraira V., and Baquero F. Scarce evidence of yogurt lactic acid bacteria in human feces after daily yogurt consumption by healthy volunteers. Applied and Environmental Microbiology 71 (2005) 547-549
6. Dieleman L.A., Goerres M.S., Arends A., Sprengers D., Torrice C., Hoentjen F., Grenther W.B., and Sartor R.B. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 52 (2003) 370-376
7. Elli M., Callegari M.L., Ferrari S., Bessi E., Cattivelli D., Soldi S., Morelli L., Goupil Feuillerat N., and Antoine J.M. Survival of yogurt bacteria in the human gut. Applied and Environmental Microbiology 72 (2006) 5113-5117
8. Fabia R., Ar'Rajab A., Johansson M.L., Willen R., Andersson R., Molin G., and Bengmark S. The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat. Scandinavian Journal of Gastroenterology 28 (1993) 155-162
9. Fujiwara M., Kaneko T., Iwana H., Taketomo N., Tsunoo H., Kanno J., Ohkusa T., and Okayasu I. Inhibitory effects of Bifidobacterium longum on experimental ulcerative colitis induced in mice by synthetic dextran sulfate sodium. Digestion 67 (2003) 90-95
10. Geier M.S., Tenikoff D., Yazbeck R., McCaughan G.W., Abbott C.A., and Howarth G.S. Development and resolution of experimental colitis in mice with targeted deletion of dipeptidyl peptidase IV. Journal of Cellular Physiology 204 (2005) 687-692
11. Gionchetti P., Rizzello F., Helwig U., Venturi A., Lammers K.M., Brigidi P., Vitali B., Poggioli G., Miglioli M., and Campieri M. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124 (2003) 1202-1209
12. Griffiths A.M. Specificities of inflammatory bowel disease in childhood. Best Practice and Research in Clinical Gastroenterology 18 (2004) 509-523
13. Guarner F., and Malagelada J.R. Gut flora in health and disease. Lancet 361 (2003) 512-519
14. Holma R., Salmenpera P., Lohi J., Vapaatalo H., and Korpela R. Effects of Lactobacillus rhamnosus GG and Lactobacillus reuteri R2LC on acetic acid-induced colitis in rats. Scandinavian Journal of Gastroenterology 36 (2001) 630-635
15. Howarth G.S., Xian C.J., and Read L.C. Insulin-like growth factor-I partially attenuates colonic damage in rats with experimental colitis induced by oral dextran sulphate sodium. Scandinavian Journal of Gastroenterology 33 (1998) 180-190
16. Howarth G.S., Xian C.J., and Read L.C. Predisposition to colonic dysplasia is unaffected by continuous administration of insulin-like growth factor-I for twenty weeks in a rat model of chronic inflammatory bowel disease. Growth Factors 18 (2000) 119-133
17. Hung J., Cooper D., Turner M.S., Walsh T., and Giffard P.M. Cystine uptake prevents production of hydrogen peroxide by Lactobacillus fermentum BR11. FEMS Microbiology Letters 227 (2003) 93-99
18. Hung J., Turner M.S., Walsh T., and Giffard P.M. BspA (CyuC) in Lactobacillus fermentum BR11 is a highly expressed high-affinity l-cystine-binding protein. Current Microbiology 50 (2005) 33-37
19. Ichikawa H., Kuroiwa T., Inagaki A., Shineha R., Nishihira T., Satomi S., and Sakata T. Probiotic bacteria stimulate gut epithelial cell proliferation in rat. Digestive Diseases and Sciences 44 (1999) 2119-2123
20. Isolauri E., Arvola T., Sutas Y., Moilanen E., and Salminen S. Probiotics in the management of atopic eczema. Clinical and Experimental Allergy 30 (2000) 1604-1610
21. Krawisz J.E., Sharon P., and Stenson W.F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87 (1984) 1344-1350
22. Kuisma J., Mentula S., Jarvinen H., Kahri A., Saxelin M., and Farkkila M. Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Alimentary Pharmacology and Therapeutics 17 (2003) 509-515
23. Kwon K.H., Murakami A., Tanaka T., and Ohigashi H. Suppressive activity of a fermented grain food product on dextran sulfate sodium-induced experimental colitis in mice. BioFactors 21 (2004) 179-184
24. Kwon K.H., Murakami A., Tanaka T., and Ohigashi H. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. Biochemical Pharmacology 69 (2005) 395-406
25. Ma D., Forsythe P., and Bienenstock J. Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infection and Immunity 72 (2004) 5308-5314
26. Madsen K.L., Doyle J.S., Jewell L.D., Tavernini M.M., and Fedorak R.N. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116 (1999) 1107-1114
27. McCarthy J., O'Mahony L., O'Callaghan L., Sheil B., Vaughan E.E., Fitzsimons N., Fitzgibbon J., O'Sullivan G.C., Kiely B., Collins J.K., and Shanahan F. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 52 (2003) 975-980
28. Moon G., Myung S.J., Jeong J.Y., Yang S.K., Cho Y.K., Lee S.M., Chang H.S., Byeon J.S., Lee Y.J., Lee G.H., Hong W.S., Kim J.H., Min Y.I., and Kim J.S. Prophylactic effect of Lactobacillus GG in animal colitis and its effect on cytokine secretion and mucin gene expressions. The Korean Journal of Gastroenterology 43 (2004) 234-245
29. Murthy S.N., Cooper H.S., Shim H., Shah R.S., Ibrahim S.A., and Sedergran D.J. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Digestive Diseases and Sciences 38 (1993) 1722-1734
30. Osman N., Adawi D., Ahrne S., Jeppsson B., and Molin G. Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium. Digestive Diseases and Sciences 49 (2004) 320-327
31. Oz H.S., Chen T.S., McClain C.J., and de Villiers W.J. Antioxidants as novel therapy in a murine model of colitis. The Journal of Nutritional Biochemistry 16 (2005) 297-304
32. Pelissier M.A., Muller C., Hill M., and Morfin R. Protection against dextran sodium sulfate-induced colitis by dehydroepiandrosterone and 7alpha-hydroxy-dehydroepiandrosterone in the rat. Steroids 71 (2006) 240-248
33. Peran L., Camuesco D., Comalada M., Nieto A., Concha A., Adrio J.L., Olivares M., Xaus J., Zarzuelo A., and Galvez J. Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis. International Journal of Colorectal Disease 21 (2006) 737-746
34. Rachmilewitz D., Katakura K., Karmeli F., Hayashi T., Reinus C., Rudensky B., Akira S., Takeda K., Lee J., Takabayashi K., and Raz E. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126 (2004) 520-528
35. Renes I.B., Verburg M., Van Nispen D.J., Taminiau J.A., Buller H.A., Dekker J., and Einerhand A.W. Epithelial proliferation, cell death, and gene expression in experimental colitis: alterations in carbonic anhydrase I, mucin MUC2, and trefoil factor 3 expression. International Journal of Colorectal Disease 17 (2002) 317-326
36. Rumi G., Tsubouchi R., Okayama M., Kato S., Mozsik G., and Takeuchi K. Protective effect of lactulose on dextran sulfate sodium-induced colonic inflammation in rats. Digestive Diseases and Sciences 49 (2004) 1466-1472
37. Sellon R.K., Tonkonogy S., Schultz M., Dieleman L.A., Grenther W., Balish E., Rennick D.M., and Sartor R.B. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infection and Immunity 66 (1998) 5224-5231
38. Setoyama H., Imaoka A., Ishikawa H., and Umesaki Y. Prevention of gut inflammation by Bifidobacterium in dextran sulfate-treated gnotobiotic mice associated with Bacteroides strains isolated from ulcerative colitis patients. Microbes and Infection 5 (2003) 115-122
39. Shibolet O., Karmeli F., Eliakim R., Swennen E., Brigidi P., Gionchetti P., Campieri M., Morgenstern S., and Rachmilewitz D. Variable response to probiotics in two models of experimental colitis in rats. Inflammatory Bowel Diseases 8 (2002) 399-406
40. Steidler L., Hans W., Schotte L., Neirynck S., Obermeier F., Falk W., Fiers W., and Remaut E. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289 (2000) 1352-1355
41. Stucchi A.F., Shofer S., Leeman S., Materne O., Beer E., McClung J., Shebani K., Moore F., O'Brien M., and Becker J.M. NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats. American Journal of Physiology: Gastrointestinal and Liver Physiology 279 (2000) G1298-G1306
42. Tomas F.M., Knowles S.E., Owens P.C., Read L.C., Chandler C.S., Gargosky S.E., and Ballard F.J. Increased weight gain, nitrogen retention and muscle protein synthesis following treatment of diabetic rats with insulin-like growth factor (IGF)-I and des(1-3)IGF-I. The Biochemical Journal 276 Pt 2 (1991) 547-554
43. Tooley K.L., Howarth G.S., Lymn K.A., Lawrence A., and Butler R.N. Oral ingestion of Streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate treated rats. Cancer Biology and Therapy 5 (2006) 593-600
44. Venturi A., Gionchetti P., Rizzello F., Johansson R., Zucconi E., Brigidi P., Matteuzzi D., and Campieri M. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Alimentary Pharmacology and Therapeutics 13 (1999) 1103-1108
45. Viljanen M., Kuitunen M., Haahtela T., Juntunen-Backman K., Korpela R., and Savilahti E. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatric Allergy and Immunology 16 (2005) 65-71
46. Vowinkel T., Kalogeris T.J., Mori M., Krieglstein C.F., and Granger D.N. Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis. Digestive Diseases and Sciences 49 (2004) 556-564
47. Yan F., and Polk D.B. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. The Journal of Biological Chemistry 277 (2002) 50959-50965
48. Zhang L., Li N., Caicedo R., and Neu J. Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. The Journal of Nutrition 135 (2005) 1752-1756